This title looks like a typo. However, if one thinks about it, this can make sense. Healthcare research and development is one of the most needed and costly activities a civilized populous must maintain. With cuts in governmental support for these programs, finance strategies need to be established that can accelerate cash flow and keep labs open.
A grant was awarded to a group of researchers studying and treating mitochondrial disorders on the cellular level. Payments by both grant issuers and by third party payors that paid for the patient’s expense in these programs were slow. Newer procedures and codes take more time for third party payors to reimburse. Xynergy Healthcare Capital was presented with an opportunity to provide one of these research facilities with an accounts receivable finance line. Following due diligence and a visit to the lab, the applicant became a client enjoying accelerated cash flow and piece of mind knowing that bills were not going to sit unpaid due to cash deficiencies.
A creative broker presented XYN with the prospect and it lead to a nice monthly dividend paid by XYN to the broker. Look to the research and development entities in heatlhcare, there may be some low hanging fruit.
Recent Comments